AllAsclepix Therapeutics AsclepiX Therapeutics, Inc. Appoints Robert J. Dempsey as Chief Executive Officer and President
AllAsclepix Therapeutics AsclepiX Therapeutics partners with Notal Vision on Home OCT remote monitoring in DME and AMD clinical trials
AllAsclepix Therapeutics AsclepiX Therapeutics, Inc. Doses First Patient in Phase 1/2a Trial of AXT107 Intravitreal Self-Forming Gel Depot Peptide for Diabetic Macular Edema (DME)
AllAsclepix Therapeutics AsclepiX Therapeutics to Present at Solebury Trout Private Company Showcase on October 15, 2020
AllAsclepix Therapeutics AsclepiX Therapeutics, Inc. Expands Leadership Team with Appointment of Industry Leader Theresa Heah, MD, MBA as Chief Medical Officer
